Joseph Y. Chang
Net worth: 1 M $ as of 2024-03-30
Profile
Joseph Y.
Chang served as the Lead Independent Director at Optimer Pharmaceuticals LLC from 2012 to 2013.
Prior to that, he was the Vice President-Clinical Studies & Pharmacology at Pharmanex, Inc. from 1998 to 2006.
He also held the position of President & Chief Scientific Officer at Binary Therapeutics, Inc. from 1994 to 1997 and at Osteoarthritis Sciences, Inc. from 1991 to 1994.
Currently, he is the Chief Scientific Officer & EVP-Product Development at Nu Skin Enterprises, Inc. since 1997.
Dr. Chang obtained a doctorate degree from the University of London in 1978 and an undergraduate degree from the University of Portsmouth.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-04-09 | 88,636 ( 0.18% ) | 1 M $ | 2024-03-30 |
Former positions of Joseph Y. Chang
| Companies | Position | End |
|---|---|---|
| NU SKIN ENTERPRISES, INC. | Chief Tech/Sci/R&D Officer | 2024-03-29 |
Optimer Pharmaceuticals LLC
 Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Director/Board Member | 2013-10-23 |
Pharmanex, Inc.
 Pharmanex, Inc. Food RetailRetail Trade Pharmanex, Inc. provided dietary supplement products. It offered anti aging with nutritional supplement products. The company was founded by William E. McGlashan Jr. and Michael N. Chang in 1994 and was headquartered in Provo, UT. | Corporate Officer/Principal | 2006-01-31 |
| Binary Therapeutics, Inc. | President | 1996-12-31 |
| Osteoarthritis Sciences, Inc. | President | 1993-12-31 |
Training of Joseph Y. Chang
| University of London | Doctorate Degree |
| University of Portsmouth | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| NU SKIN ENTERPRISES, INC. | Consumer Non-Durables |
| Private companies | 4 |
|---|---|
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Health Technology |
Pharmanex, Inc.
Pharmanex, Inc. Food RetailRetail Trade Pharmanex, Inc. provided dietary supplement products. It offered anti aging with nutritional supplement products. The company was founded by William E. McGlashan Jr. and Michael N. Chang in 1994 and was headquartered in Provo, UT. | Retail Trade |
| Binary Therapeutics, Inc. | |
| Osteoarthritis Sciences, Inc. |
- Stock Market
- Insiders
- Joseph Y. Chang
